SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2.96 |
Enterprise Value ($M) | 2.40 |
Book Value ($M) | -0.71 |
Book Value / Share | -0.19 |
Price / Book | -4.16 |
NCAV ($M) | -0.78 |
NCAV / Share | -0.21 |
Price / NCAV | -3.81 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -2.09 |
Return on Equity (ROE) | -4.16 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.70 |
Current Ratio | 0.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 2.90 |
Assets | 2.96 |
Liabilities | 3.68 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Intracoastal Capital, Llc | 4.99 | 262.87 | |
13G/A | Hudson Bay Capital Management LP | 1.35 | -95.07 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,172 | 30,429 | 17.00 | |
5,246 | 45,473 | 11.54 | |
3,505 | 13,560 | 25.85 | |
10,584 | 40,958 | 25.84 | |
36,861 | 149,710 | 24.62 | |
(click for more detail) |
Similar Companies | |
---|---|
BMRA – Biomerica, Inc. | BNTC – Benitec Biopharma Inc. |
BON – Bon Natural Life Limited | BTAI – BioXcel Therapeutics, Inc. |
BYSI – BeyondSpring Inc. |
Financial data and stock pages provided by
Fintel.io